A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study. [electronic resource]
Producer: 20160823Description: 15-22 p. digitalISSN:- 1421-9794
- Adenocarcinoma, Clear Cell -- mortality
- Adenocarcinoma, Mucinous -- mortality
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cohort Studies
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Cystadenocarcinoma, Serous -- mortality
- Endometrial Neoplasms -- mortality
- Female
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation
- Humans
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Staging
- Ovarian Neoplasms -- mortality
- Prognosis
- Salvage Therapy
- Survival Rate
- Topotecan -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.